Journal of South Asian Federation of Obstetrics and Gynaecology

Register      Login

VOLUME 12 , ISSUE 4 ( July-August, 2020 ) > List of Articles


Cardiomyopathy in Pregnancy with COVID-19: An Enigma

Shraddha Ashok Mevada, Madhuri Alap Mehendale, Priyanka Murlidhar Gite, Nadiya Saeed Khan

Citation Information : Mevada SA, Mehendale MA, Gite PM, Khan NS. Cardiomyopathy in Pregnancy with COVID-19: An Enigma. J South Asian Feder Obs Gynae 2020; 12 (4):243-244.

DOI: 10.5005/jp-journals-10006-1810

License: CC BY-NC 4.0

Published Online: 28-09-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Background: The coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health emergency. Physiological and mechanical changes in pregnancy increase susceptibility to infections in general, particularly when the cardiorespiratory system is affected, and encourage rapid progression to respiratory and heart failure in the gravida. Case description: We present a case report of 30-year-old primigravidae with 36.5 weeks by date and 37 week by scan with diagnosed preeclampsia 2 weeks back on medication with 11 × 10.4 × 10.9 cm single intramural anterior wall fibroid with breech presentation. COVID nasopharyngeal sample reported as SARS-CoV-2 real-time PCR positive. The patient was started on medication defining the Stage 1 Group A Asymptomatic Category. Chest X-ray showed mild bilateral pulmonary infiltrates. On Day 6 of admission, the patient went in labor, and hence was taken for emergency LSCS in view of primigravidae with breech with preeclampsia with fibroid with PROM under spinal anesthesia with all precautions. Intraoperatively, the LSCS was uneventful. Postoperatively 6 hours postpartum, the patient developed sudden onset breathlessness NYHA Grade 4, with saturation of 56%, and patient was intubated and shifted to ICU. Chest X-ray revealed viral pneumonia, and further 2D ECHO was suggestive of cardiomyopathy. Conclusion: We suggest an echocardiogram in pregnant women with coronavirus disease 2019 pneumonia, in particular those necessitating oxygen or those who are critically ill. Clinical significance: Viral myocarditis and cardiomyopathy have been reported in nonpregnant COVID-19 patients. Information on COVID-19 in pregnancy is currently limited. No specific literature is available of viral cardiomyopathy reported in pregnant women with COVID-19 infection.

  1. Phenotypic and metabolic characteristics of monocytes andgranulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol 2001;185(5):1118–1123. DOI: 10.1067/mob.2001.117682.
  2. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5(7):811–818. DOI: 10.1001/jamacardio.2020.1017.
  3. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020;323(16):1612–1614. DOI: 10.1001/jama.2020.4326.
  4. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020;2(2):100107. DOI: 10.1016/j.ajogmf.2020.100107.
  5. Coronavirus disease 2019 in pregnancy: early lessons. Am J Obstet Gynecol MFM 2020;2(2):100111. DOI: 10.1016/j.ajogmf.2020.100111.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.